With political presence, the first laboratories of the Fraunhofer site for immunology, infection and pandemic research were opened today in Penzberg/Munich at Roche. The aim of the new Fraunhofer site is to identify and characterize pandemic pathogens and to develop new diagnostics and therapies. In collaboration with Roche, Ludwig-Maximilians-Universität-Munich and LMU Klinikum in Großhadern/Martinsried, Fraunhofer aims to advance precision medicine. Networking will bring the already strong biotech locations even closer together – to form an ecosystem with international appeal.
The site is headed by Michael Hölscher, who is also part of the bayresq.net research network.
The full article can be found here.
Cover photo: © Bernhard Huber Fotografie
